Get Cheapest Tirzepatide Prescription Online
Tirzepatide — the dual-action GLP-1 behind Zepbound and Mounjaro — prescribed through a free telehealth consultation. Programs start at $299/month, your doctor matches the right product to you, and you're only charged after approval.
Tirzepatide results from the SURMOUNT-1 trial
The numbers that made tirzepatide famous, from its 72-week pivotal weight-management study at the 15 mg dose.
SURMOUNT-1 results at the 15 mg dose (efficacy estimand), alongside a reduced-calorie diet and increased activity. Individual results vary; your dose and results are managed by your doctor.
Tirzepatide Online Program
Starting price — free doctor consultation included. Billed monthly, and you're only charged once a licensed doctor approves your prescription.
- No membership and no subscription, ever
- Self-pay pricing with no insurance required
- Zepbound or Mounjaro, matched to you by your doctor
- Tirzepatide prescription based on a telehealth consultation
- Ongoing dose adjustments and refills online
- Discreet shipping with tracking
No charge until your tirzepatide is approved
Booking is free. A licensed doctor reviews your health history in a private video or phone visit, and if tirzepatide isn't right for you, you won't be charged for medication. That's the same worry-free promise behind everything we prescribe.
- Program starts at $299/month — dose-based pricing shown up front
- Free consultation — pay only after approval
- Prescription typically issued in 10–15 minutes after approval
- Cancel anytime, no long-term contract
- Prefer a daily tablet? Wegovy pills from $149/mo
How to get tirzepatide online in 3 steps
From booking to your first shipment — private, fast, and risk-free until a doctor approves you.
Book your free consultation
Pick a time that suits you — scheduling is open 24/7 with same-day slots. Booking takes about two minutes and costs nothing.
Meet your doctor online
A licensed U.S. physician reviews your health history, medications, and goals by private video or phone — then matches you to Zepbound or Mounjaro if tirzepatide is right for you.
Approved, shipped, supported
Your prescription is typically issued within 10–15 minutes of approval. Medication ships discreetly with tracking, and refills plus dose adjustments are handled online.
Zepbound or Mounjaro — your doctor decides
Both contain tirzepatide. The right one depends on your health history — that's exactly what your consultation determines.
| Zepbound | Mounjaro | |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide |
| FDA-approved for | Chronic weight management | Type 2 diabetes |
| Typical fit | BMI 30+, or 27+ with a weight-related condition | Patients whose diabetes care includes tirzepatide |
| Format | Once-weekly injection | Once-weekly injection |
| In our program | Matched by your doctor | Matched by your doctor |
Built to remove every barrier between you and treatment
Transparent, flat pricing
From $299/month with dose-based pricing displayed before any charge — no membership fees, no insurance paperwork, and no prior-authorization limbo.
Real medical oversight
A licensed doctor screens you before prescribing and stays with you after — check-ins, dose titration, and answers when side effects or questions come up.
Two paths, one platform
Tirzepatide injections from $299/mo, or needle-free Wegovy pills from $149/mo — compare them in our honest guide and let your doctor recommend the fit.
What to know before starting tirzepatide
Tirzepatide shares the GLP-1 class profile: nausea, constipation, diarrhea, and stomach discomfort are the most common side effects, typically easing as your doctor titrates the dose gradually, with injection-site reactions also possible. Rarer serious risks — pancreatitis, gallbladder issues, and thyroid-related contraindications — are exactly what your consultation screens for, and why tirzepatide is prescription-only. Eligibility generally follows standard criteria: BMI 30+, or 27+ with a weight-related condition. Availability varies by state and is confirmed during booking across all 50 states.
Tirzepatide program — frequently asked questions
This page is general information, not medical advice. Prescriptions are issued solely at a licensed clinician's discretion, and not everyone qualifies. Individual results vary.
Tirzepatide by state
See how the tirzepatide program works where you live — every state has its own guide, with availability confirmed at booking.
Important Safety Information & Disclaimers
About treatment results
Individual results vary. The figures cited on this page come from SURMOUNT-1, a 72-week randomized, double-blind, placebo-controlled trial of tirzepatide in adults with obesity, published in the New England Journal of Medicine (Jastreboff et al., 2022), in which participants also followed a reduced-calorie diet and increased physical activity. Your outcome depends on many factors, including dose, diet, physical activity, sex, baseline weight, other health conditions, and how consistently you follow your treatment plan. Tirzepatide — marketed as Zepbound® and Mounjaro® — should only be used under the supervision of a licensed healthcare provider.
Common side effects
According to FDA prescribing information, the most common side effects of tirzepatide include nausea, diarrhea, vomiting, constipation, decreased appetite, indigestion, fatigue, and headache. These are typically most noticeable when starting treatment or increasing a dose, and often lessen as the body adjusts under a clinician-guided titration schedule.
Boxed warning and serious risks
Tirzepatide carries a boxed warning: in rodent studies it caused thyroid C-cell tumors, and it is not known whether it causes medullary thyroid carcinoma (MTC) in humans. Do not use tirzepatide if you or a family member has a history of MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Other serious risks described in prescribing information include pancreatitis, gallbladder disease, kidney injury (often linked to dehydration from vomiting or diarrhea), severe allergic reactions, and changes in mood. Monitor for new or worsening depression or suicidal thoughts; contact your provider promptly if they occur, and in the U.S. you can call or text 988 (Suicide & Crisis Lifeline) in a mental-health emergency.
Who should not take tirzepatide
Do not use tirzepatide if you have the thyroid-related history above, if you have had a serious allergic reaction to tirzepatide or any of its ingredients, or during pregnancy or breastfeeding — safety data in these populations is limited, and treatment should be stopped in consultation with your provider if you become pregnant. Always give your prescribing clinician a complete medication and health history so interactions and contraindications can be screened properly.
Approved uses and off-label use
Zepbound® is FDA-approved for chronic weight management in adults who meet eligibility criteria; Mounjaro® is FDA-approved for type 2 diabetes. Any off-label use — including dose splitting or microdosing — should only occur under the direction of a licensed healthcare professional who knows your history.
Pricing and availability
Access to medications, manufacturer savings programs, and pharmacy stock varies by location, insurance status, and pharmacy participation. WegovyPills.org is not responsible for third-party pricing, availability, or reimbursement policies, and program pricing on this page reflects our platform only.
Reporting side effects
Suspected adverse reactions can be reported to the FDA MedWatch program at fda.gov/medwatch or by calling 1-800-FDA-1088. Reporting helps regulators monitor medication safety for everyone.
Scope of this page
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is written to be consistent with FDA prescribing information and peer-reviewed research current as of the review date above. Always consult a licensed healthcare provider for personal medical decisions, and never start, stop, or change a medication based on a website alone.
Sources
- Zepbound® Prescribing Information — U.S. Food & Drug Administration
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — New England Journal of Medicine, 2022
- Postmarket Drug Safety Information — U.S. Food & Drug Administration
- Tirzepatide Product Information — Eli Lilly and Company
- Mounjaro® Official Website — Eli Lilly and Company
- Product Resources — Novo Nordisk A/S
Trademarks
Zepbound®, Mounjaro®, and Trulicity® are registered trademarks of Eli Lilly and Company. Ozempic®, Rybelsus®, Wegovy®, Saxenda®, and Victoza® are registered trademarks of Novo Nordisk A/S. This website is not affiliated with, endorsed by, or sponsored by these companies; brand names are used for identification, education, and comparison only.
Start your tirzepatide consultation today.
Book free in about two minutes — same-day slots available. A licensed doctor matches you to Zepbound or Mounjaro if tirzepatide is right for you, with prescriptions typically issued in 10–15 minutes after approval. You're only charged after approval.
Book an Appointment